{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"x-linked-intellectual-disability-seizures-psoriasis-syndrome","columns":[{"gene":"","key":"MONDO:0010652/ORPHA:3052","label":"X-linked intellectual disability-seizures-psoriasis syndrome","mondoId":"MONDO:0010652","onsetQualifier":null,"recordKeys":["07cc8eb13371ae1a215afd0169cdf5c4854246eaed4e22bdd09075b78348031f","2631a54c9bab05096155408d33d6a6136854c36bcf439d4ba4e84ff91be40fd2","5d77ed5beb069904229e9281cccebcd51af283d10aaa1d6721807c904dd9fc3f","879ae96ba16dc531493a63df92f22f72b276fec67298854c107a588d4d88837f","b06f3a27ac9ee9455038b990656a63fa9037d0e47b0f8206698013fc7d3aac27"],"recordQualifiers":{},"scopeLabel":"ORPHA:3052","sourceIds":["ORPHA:3052"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0010652/ORPHA:3052"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":0,"orphanet":5,"published":0}},"features":[{"hpoId":"HP:0008064","label":"Ichthyosis","primary":false},{"hpoId":"HP:0003538","label":"Increased iduronate sulfatase level","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0003765","label":"Psoriasiform dermatitis","primary":false},{"hpoId":"HP:0001250","label":"Seizures","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0010652","records":[{"frequencyKind":"reported","key":"07cc8eb13371ae1a215afd0169cdf5c4854246eaed4e22bdd09075b78348031f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:3052","disease_name":"X-linked intellectual disability-seizures-psoriasis syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003538","is_excluded":true,"label":"Increased iduronate sulfatase level","onset_id":null,"reference":"ORPHA:3052","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2631a54c9bab05096155408d33d6a6136854c36bcf439d4ba4e84ff91be40fd2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:3052","disease_name":"X-linked intellectual disability-seizures-psoriasis syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:3052","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d77ed5beb069904229e9281cccebcd51af283d10aaa1d6721807c904dd9fc3f","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:3052","disease_name":"X-linked intellectual disability-seizures-psoriasis syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003765","is_excluded":false,"label":"Psoriasiform dermatitis","onset_id":null,"reference":"ORPHA:3052","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"879ae96ba16dc531493a63df92f22f72b276fec67298854c107a588d4d88837f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:3052","disease_name":"X-linked intellectual disability-seizures-psoriasis syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:3052","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b06f3a27ac9ee9455038b990656a63fa9037d0e47b0f8206698013fc7d3aac27","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:3052","disease_name":"X-linked intellectual disability-seizures-psoriasis syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008064","is_excluded":true,"label":"Ichthyosis","onset_id":null,"reference":"ORPHA:3052","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"x-linked-intellectual-disability-seizures-psoriasis","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"X-linked intellectual disability-seizures-psoriasis syndrome"},"schemaVersion":1}